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Abstract
Objective: To describe the diagnosis and management of 
severe peripartum cardiomyopathy.
Methods: A case report.
Case: A 35-year-old woman presented with dyspnea and 
leg edema. The patient gave birth 3 months ago. The 
hemodynamic was unstable and the physical examination 
showed a mild rhonchi in the basal of the lung and 
pansystolic murmur in the apex. Echocardiography showed 
a dilated heart chamber and reduced ejection fraction (30%). 
The patient was diagnosed as severe PPCM. The initial 
management was to stabilize the patient using furosemide, 
catecholamine, and vasopressor administration. After the 
patient’s condition was stable, ramipril, bisoprolol, and 
bromocriptine were given as heart failure therapy.
Conclusions: Patient with suspicion of PPCM should be 
managed thoroughly from detailed history taking to proper 
diagnostic testing such as echocardiography. Prompt 
treatment of severe PPCM according to the guideline will 
improve the cardiac function.
Keywords: catecholamines, echocardiography, peripartum 
cardiomyopathy, pregnancy, vasopressor.
Abstrak
Tujuan: Untuk mendeskripsikan mengenai diagnosis dan 
manajemen pasien pada kasus kardiomiopati peripartum 
yang berat.
Metode: Laporan kasus.
Kasus: Seorang Perempuan 35 tahun datang dengan 
dispnea dan edema tungkai. Pasien melahirkan 3 bulan 
lalu. Hemodinamik tidak stabil dan pemeriksaan fisik 
menunjukkan ronki ringan di basal paru dan murmur 
pansistolik di apeks. Ekokardiografi menunjukkan dilatasi 
ruang jantung dan fraksi ejeksi berkurang (30%). Pasien 
didiagnosis dengan PPCM berat. Penatalaksanaan awal 
adalah menstabilkan pasien dengan pemberian furosemid, 
katekolamin, dan vasopresor. Setelah kondisi pasien stabil, 
diberikan ramipril, bisoprolol, dan bromokriptin sebagai 
terapi gagal jantung.
Kesimpulan: Pasien dengan kecurigaan PPCM harus 
dikelola secara menyeluruh mulai dari anamnesa yang rinci 
hingga uji diagnostik yang tepat seperti ekokardiografi. 
Pengobatan segera untuk PPCM derajat berat yang sesuai 
dengan pedoman akan meningkatkan fungsi jantung.
Kata kunci: ekokardiografi, kardiomiopati peripartum, 
katekolamin, kehamilan, vasopressor.
Received: October 28, 2020 Accepted:  Published: 
INTRODUCTION
Peripartum cardiomyopathy (PPCM) is a rare 
condition that could be life-threatening. It is 
characterized by a disruption in systolic phase 
and the presence of sign and symptoms of heart 
failure at the end of pregnancy and first 5 months 
after the delivery process, with left ventricular 
ejection fraction (LVEF) <45%.1 PPCM is different 
from other heart failure. Diagnosis of PPCM is 
made after excluding any other possible causes 
of heart failure (pregnancy-related myocardial 
infarction and pre-existing heart disease).2
The incidence of PPCM differs in numerous 
countries. In USA, the overall incidence from 
2004 to 2011 was about 1 in 968 live births.3 
Nigeria and Haiti reported a higher incidence; 
1 in 100 pregnancies and 1 in 300 pregnancies 
respectively.4 The study about PPCM incidence 
in Asia is lacking. However, a study showed that 
the incidence of PPCM was about 1 in 3.790 live 
births.5 Heart dysfunction in PPCM may cause 
After diagnosing the patient with severe 
PPCM because of the hemodynamic instability, 
we initiated the treatment with furosemide 
IV drip, followed by the administration of 
dobutamine. We also corrected the hypocalcemia 
complications that range from mild (shortness 
of breath and swelling of the leg) to severe 
(cardiogenic shock and death). The mortality 
rates of PPCM was reported to be as high as 
30% worldwide.4 Risk factors for PPCM may vary 
from hypertensive disorders, older age during 
pregnancy, and also African population.1
Although the definition and diagnostic criteria 
of PPCM is already available, PPCM may present 
a challenge for physician in clinical settings 
because of the nonspecific signs and symptoms 
that could be similar to the physiologic changes in 
pregnancy. Therefore, it is important to evaluate 
pregnant/post-partum woman with heart failure 
symptoms.4 The purpose of this case report is to 
share the knowledge about how to diagnose and 
treat patients with severe PPCM based on our 
experience in managing 35-years-old woman 
with PPCM.
CASE
A 35-year-old woman came to the emergency 
room, with shortness of breath and leg edema 
in the last 3 months after given birth to her first 
baby. She reported that the shortness of breath 
was exacerbated by activity. She did not check 
herself to the doctor earlier because she thought 
that this was normal in pregnancy. There was no 
similar symptom and no history of hypertension 
during the pregnancy. The patient looked ill 
with GCS E4V5M6. The initial examination for 
vital signs were notable with blood pressure of 
86/50 mmHg, heart rate of 110 beats/minute, 
respirations of 28x/minute, and oxygen saturation 
of 95% on room air. The patient did not have 
fever. 
As an initial management, we gave oxygen 
to the patient 3 liter/minute with nasal canule. 
Through the physical examination, we found 
a grade 4 pansystolic murmur at the apex. We 
also found mild rhonchi at the basal of the lung. 
We conducted an electrocardiography on the 
patient. The result showed a sinus tachycardia 
with heart rate of 125 beats/minute with right 
axis deviation. There was also an inverted T wave 
at III, V5, V6, and aVF. The ECG also showed a 
right atrial dysfunction, left atrial enlargement, 
and incomplete left bundle branch block (LBBB). 
Ventricular extrasystole was also found at lead I 
and III (figure 1). Blood test was done and the 
result showed a shift-to-the right leukocyte 
count. The electrolyte evaluation showed a mild 
hyponatremia (131 mmol/L), hyperchloride (109 
mmol/L), and hypocalcemia.  The urinalysis was 
negative for proteins.
We decided to perform echocardiography 
to evaluate the heart of the patient. The left 
ventricular internal diameter end diastole (LVIDd) 
was 5.71cm and the left ventricular internal 
diameter end systole (LVIDs) was 4.53cm, 
suggestive of an increased diameter of the left 
ventricle (figure 2). The mitral valve showed 
a moderate to severe regurgitation and the 
tricuspid was mild to moderate regurgitation, 
supported by Doppler examination. The patient 
had a reduced LVEF (30%). Echocardiography 
prior to pregnancy, the LVEF was normal (61%) 
with mild mitral regurgitation due to mitral 
valve prolapse. From the result of thorough 
examination, the diagnosis of severe peripartum 
cardiomyopathy was made.
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Figure 1. ECG of the patient showed T-wave inversion at III, 
V5, V6, and aVF right atrial dysfunction, left atrial enlargement, 
and incomplete left bundle branch block (LBBB), and ventricular 
extrasystole at I and III
Figure 2. Echocardiography showed a dilated left ventricle.
with calcium gluconate IV. However, no 
improvement can be seen in the patient, so that 
we added norepinephrine. The administration of 
norepinephrine improved the hemodynamic of 
the patient. The patient was monitored closely 
and her condition kept on improving until 
declared stable. The patient was prescribed with 
oral bromocriptine, ramipril, and bisoprolol. She 
was then discharged from the hospital after three 
days of treatment and was being monitored in 
outpatient clinic.
DISCUSSION
The diagnosis of PPCM is a diagnosis of 
exclusion. The physician needs to exclude other 
etiologies of heart failure in the patient. Initial 
history taking is essential to collect the data of 
any pre-existing cardiac dysfunction, whether 
during or before the pregnancy. Patients with 
PPCM may present with dyspnea, orthopnea, 
edema, palpitation, and impairment of activity.6 
To establish the diagnosis, the physician should 
conduct an echocardiography examination. ECG 
can also be performed at the beginning.
ECG is an easily accessible and safe tool to 
evaluate the patients. Several patterns could 
appear such as inversion of T-wave and bundle 
branch block. T-wave inversion is more common 
than the other pattern and is negatively correlated 
with the systolic function (p= 0.03). T-wave 
inversion pattern at the baseline is also associated 
with a persistent systolic dysfunction until six 
months after the first diagnosis.7 The ECG of our 
patient also showed a pattern of LBBB, which is 
a sign of cardiomyopathy.8 Echocardiography 
is important in examining the left ventricular 
ejection fraction (LVEF). In PPCM cases, we would 
find the LVEF to be < 45%. Echocardiography 
is able to find a dilatation of the chamber and 
M-mode fractional shortening <30%.9,10 Mitral 
regurgitation may appear in PPCM due to left 
ventricular dilation.11 Echocardiography is also 
capable to exclude other diagnosis. Patients who 
present with diastolic dysfunction but with good 
systolic function should be suspected to have 
preeclampsia.12
Furthermore, these several criteria can be used 
in making the diagnosis of PPCM. The criteria 
include the presence of left ventricular systolic 
dysfunction from echocardiography examination 
in the peripartum period, the onset of the 
symptoms during the last month of pregnancy 
and 5 months post-partum, no other etiologies 
of heart failure, and no evidence of heart disease 
before the last month of pregnancy.9
Diuretic should always be prepared to be 
administered to PPCM patients especially in 
emergency settings. Two types of diuretic, loop 
and thiazide, were recommended as the initial 
treatment for moderate and severe PPCM 
patient.13 Both are considered to be safe during 
pregnancy but there is a very limited data on 
furosemide usage during lactation.14 We initiated 
furosemide IV drip in this patient because the 
patient did not breastfeed.
Norepinephrine is recommended to be the 
first-line treatment for patient with classic wet 
and cold presentation while dobutamine is 
added when the patient stabilizes.15 However, 
the recommendation can be considered to 
oversimplify the management of cardiogenic 
shock in clinical practice because the treatment 
should not only be focused on improving blood 
pressure. A review conducted recommended that 
there are three aspects that should be assessed 
in treating patient with cardiogenic shock which 
are metabolic optimization, pump function 
optimization, and tissue perfusion optimization.16 
The main problem within the patient was the 
inadequate left ventricle contractility so that we 
administered dobutamine to optimize the pump 
function. However, since the administration of 
maximum dose dobutamine did not improve 
the blood pressure, we added norepinephrine. 
Currently, there is no study that directly 
compared the efficacy and safety of dobutamine 
and norepinephrine combination to dobutamine 
in heart failure patient, let alone in PPCM patient. 
A study conducted by Levy B et al concluded that 
epinephrine was as effective as the combination 
of norepinephrine and dobutamine in improving 
global hemodynamic effect of cardiogenic shock 
patients, but the combination was more reliable 
and safer.17
The existing guideline in the management 
of PPCM by ESC based on multiple trials 
suggested that bromocriptine should be 
given in PPCM patients with any severity. The 
treatment is differentiated into two groups: the 
uncomplicated patients (1 week treatment, 2.5 
mg once daily) and complicated patients with 
EF <25%, right ventricular involvement, intensive 
care treatment, and/or cardiogenic shock (2.5 
mg twice daily for two weeks and 2.5 mg once 
daily for 6 weeks).15 Therefore, we prescribed 
the patient with bromocriptine for 8 weeks. In 
addition to bromocriptine, we added ramipril and 
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bisoprolol as regular oral HF drugs. ACE-inhibitor 
is suggested to be given to patient that did not 
breastfeed and contraindicated to be given in 
pregnant patient, while beta-blockers should 
be prescribed to all PPCM patients (pregnant or 
after delivery).15
CONCLUSION
Peripartum cardiomyopathy is a rare condition 
in daily practice, yet causes a high mortality 
rate. It may not be easy to diagnose because 
the symptoms are not specific and may present 
in normal pregnancy. Good history taking 
and diagnostic testing may help to make the 
diagnosis. Echocardiography is an important 
tool to evaluate the cardiac function and rule 
out the other cause of cardiomyopathy. Proper 
management can improve the clinical symptoms 
and improve the cardiac function.
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